LPL Financial LLC

Position in PBYI — Puma Biotechnology, Inc.

CIK 1403438 FORT MILL, SC

Position in PBYI

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$280,095

+$46,106 QoQ

Shares Held

34,537

-5.7% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#68

of 160 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

LPL Financial LLC holds $557,763,742 across 203 Biotechnology names. PBYI ranks #129 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	289,111	$143,610,107
2	REGN	Regeneron Pharmaceuticals, Inc.	65,755	$41,000,872
3	ARWR	Arrowhead Pharmaceuticals, Inc.	310,761	$25,330,129
4	ARGX	Argenx SE	19,499	$18,090,587
5	ALNY	Alnylam Pharmaceuticals, Inc.	57,890	$17,426,626
6	HALO	Halozyme Therapeutics, Inc.	203,557	$15,932,406
7	RPRX	Royalty Pharma plc	249,117	$13,967,990
8	INSM	INSMED Inc	128,553	$13,706,320

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$280,095	34,537	-5.7%	Shares	Sole	2026-08-07
2026-03-31	$233,989	36,618	-9.5%	Shares	Sole	2026-05-06
2025-12-31	$240,629	40,442	-21.2%	Shares	Sole	2026-02-11
2025-09-30	$272,418	51,303	-3.7%	Shares	Sole	2025-11-12
2025-06-30	$182,794	53,293	+23.1%	Shares	Sole	2025-08-12
2025-03-31	$128,147	43,293	+63.0%	Shares	Sole	2025-05-07
2024-12-31	$81,029	26,567	+23.6%	Shares	Sole	2025-02-11
2024-09-30	$54,791	21,487	+3.9%	Shares	Sole	2024-11-08
2024-06-30	$67,407	20,677	0.0%	Shares	Sole	2024-08-07
2024-03-31	$109,588	20,677	+89.3%	Shares	Sole	2024-05-10
2023-12-31	$47,296	10,923	+4.8%	Shares	Sole	2024-02-14
2021-09-30	$73,044	10,420	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.